---
title: "Weight Watchers Expands Med+ With Access to New Ozempic® pill (semaglutide) | WW Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/284894992.md"
description: "Weight Watchers Expands Med+ With Access to New Ozempic® pill (semaglutide) | WW Stock News"
datetime: "2026-05-01T04:05:37.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/284894992.md)
  - [en](https://longbridge.com/en/news/284894992.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/284894992.md)
---

# Weight Watchers Expands Med+ With Access to New Ozempic® pill (semaglutide) | WW Stock News

Weight Watchers Expands Med+ With Access to New Ozempic® pill (semaglutide) | WW Stock News

### Related Stocks

- [WW.US](https://longbridge.com/en/quote/WW.US.md)
- [WGHTQ.US](https://longbridge.com/en/quote/WGHTQ.US.md)

## Related News & Research

- [Galloway Capital Partners Announces Investment in WW International and Believes Shares Are Worth Multiples of Current Price](https://longbridge.com/en/news/286281620.md)
- [Bruce Galloway Takes Activist Stake at WW International with 8.42% Stake](https://longbridge.com/en/news/286276602.md)
- [Key facts: Novo Nordisk early −21.6% 64w; Rexall delivery Canada](https://longbridge.com/en/news/286343869.md)
- [Rybelsus brand retired in US as ‘Ozempic pill’ takes the stage](https://longbridge.com/en/news/285061462.md)
- [A Look At Beam Therapeutics (BEAM) Valuation As New BEACON Trial Data And Partnerships Draw Attention](https://longbridge.com/en/news/286662919.md)